Due to the COVID-19 outbreak the 8th Fernö Breast Cancer Symposium will be postponed until next year - autumn 2021
The 8th Fernö Breast Cancer Symposium
Age-related aspects of breast cancer
Preliminary program 8th Fernö Breast Cancer symposium.
Speakers and universities.
Use these guidelines.
Supported by The Swedish Breast Cancer Association
and the Swedish Cancer Society.
Welcome to the 8th Fernö Breast Cancer Symposium, 8th – 9th October 2020 at Wärdshuset Lasse Maja, Stockholm Järfälla
Registration date: 2020-06-09
Late registration date: 2020-09-01
Abstract submission date: 2020-09-01
Use these guidelines: Download Abstract Submission Guidelines
Early registration: 2.900 SEK (excl VAT)
Late registration: 3.700 SEK (excl VAT)
The Swedish Translational Research in Breast Cancer (Swe-TRIBE) group is a national group of translational researchers all working within the field of breast cancer. The aim of Swe-TRIBE is to stimulate translational breast cancer research across Sweden with the ultimate aim of paving the way for clinical implementation of research findings. The Swedish Cancer Society financially supports the work of Swe-TRIBE.
Swe-TRIBE organizes an annual translational symposium. We encourage junior and senior researchers to join as participants at the symposium to create a fruitful environment. This is a great opportunity to present your research as well as meeting and interacting with other researchers working within the breast cancer field. This year we again have the honour to welcome a plethora of distinguished speakers. Please see this year’s program below.
Thursday October 8
09:00–10:00 Registration and coffee
10:00–10:15 Welcome and introduction: Linda Lindström and Sophia Zackrisson, Chairmen Swe-TRIBE
Session 1 | Epidemiological challenges
10:15–10:55 KEYNOTE: Epidemiological challenges in understanding the impact of age on risk, incidence, mortality in breast cancer | Lars Holmberg
11:00–11:40 KEYNOTE: What are the main problems in younger vs older women from a clinical perspective? | Speaker TBA
Session 2 | Molecular aspects
11:45–12:25 KEYNOTE: Molecular aspects, tumor biology and age| Speaker TBA
Session 3 | Age-individualized rehabilitation in breast cancer
13:30–13:55 Individualized rehabilitation after primary breast cancer surgery | Marlene Malmström
14:00–14:25 Patient perspective | Susanne Dieroff-Hay, Bröstcancerförbundet
Selected Oral Presentations
17:30–18:15 Free time
Poster mingle’n drinks (2-min-presentations)
Friday October 9
Session 4 | Treatment and clinical aspects
08:30–08:55 Fertility preservation after breast cancer| Speaker TBA
09:00–09:25 Breast cancer treatment in elderly | Barbro Linderholm
09:30–09:55 Radiation therapy in older women| Speaker TBA
10:00–10:30 Coffee break
Session 5 | Age of the tumor – molecular/biological aspects
10:30–10:55 Molecular and genetic perspectives| Speaker TBA
11:00–11:25 Pregnancy-related breast cancer| Speaker TBA
11:30–11:55 Biology, long term risk and tumor dormancy| Speaker TBA
12:00–12:15 Summary and thank you
More to be announced